FDA weighs first-ever OTC birth control pill
The Food and Drug Administration is reviewing a first-of-its-kind application from HRA Pharma for Opill. If green-lit by the agency, Opill would become the first daily, hormonal birth control pill sold without a prescription. The submission of the application follows more than six years of studies the company has run. Alice Miranda Ollstein reports.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Food and Drug Administration is reviewing a first-of-its-kind application from HRA Pharma for Opill. If green-lit by the agency, Opill would become the first daily, hormonal birth control pill sold without a prescription. The submission of the application follows more than six years of studies the company has run. Alice Miranda Ollstein reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices